On ECHEMI
Home > Drugs > Ecabet sodium Registered Holders
Ecabet sodium structure

Ecabet sodium structure

Ecabet sodium

Ecabet sodium (TA-2711) is currently applied to some clinical gastrointestinal disease by inhibiting the ROS production and improving Helicobacter pylori eradication[1]. Ecabet sodium reduces apoptosis[2].

Find 4 Related Holders

Jiangxi Oushi Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2004-10-27
  • Country:

    China China
  • Address:

    No. 1115, Saiwei Avenue, Xinyu High-tech Industrial Park, Jiangxi Province
  • Tax NO.:

    91360500763353824Q
  • Registered Funds:

    23 million yuan
  • Website:

  • Email:

Changzhou Yabang Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2002-10-18
  • Country:

    China China
  • Address:

    No. 6, Liangchang East Road, Jintan District, Changzhou
  • Tax NO.:

    91320413743704842G
  • Registered Funds:

    70 million yuan
  • Website:

  • Email:

Yuanda Pharmaceutical (Tianjin) Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    1993-10-15
  • Country:

    China China
  • Address:

    No. 16, Weisan Road, Microelectronics Industrial Zone, Tianjin Economic and Technological Development Zone
  • Tax NO.:

    91120116600576732H
  • Registered Funds:

    110.533424 million yuan
  • Email:

JUZEN CHEMICAL CORP
United States United States

API Registration Country

API Inactive
Recommended Suppliers of Ecabet sodium
View 17 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.